Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / S&P BIOTECH
-
Number of holders
-
550
-
Total 13F shares, excl. options
-
80,394,761
-
Shares change
-
-216,582
-
Total reported value, excl. options
-
$8,962,587,757
-
Value change
-
-$25,560,323
-
Put/Call ratio
-
312%
-
Number of buys
-
272
-
Number of sells
-
-207
-
Price
-
$111.43
Significant Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q3 2020
676 filings reported holding XBI - SPDR SERIES TRUST - S&P BIOTECH as of Q3 2020.
SPDR SERIES TRUST - S&P BIOTECH (XBI) has 550 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80,394,761 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (12,074,187 shares), MORGAN STANLEY (11,485,411 shares), JPMORGAN CHASE & CO (10,539,489 shares), CITIGROUP INC (7,963,810 shares), BANK OF AMERICA CORP /DE/ (7,422,349 shares), BNP PARIBAS ARBITRAGE, SA (4,711,655 shares), BARCLAYS PLC (4,490,173 shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (2,334,000 shares), UBS Group AG (2,283,812 shares), and WELLS FARGO & COMPANY/MN (1,156,259 shares).
This table shows the top 550 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.